The research teams at the University of Hong Kong led by Professor Xuechen Li from the Research Division for Chemistry and Department of Chemistry, and Professor Yu Wang from the Department of Pharmacology and Pharmacy, reported a synthetic biotherapeutics with promising anti-tumor, insulin sensitizing and hepatoprotective activities in the Journal of the American Chemical Society.